La vendita allo scoperto per Franklin FTSE United Kingdom ETF dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Franklin FTSE United Kingdom ETF. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Franklin FTSE United Kingdom ETF (ARCA:FLGB), Report sulle vendite allo scoperto

Franklin FTSE United Kingdom ETF

<a href="https://www.gothamcityresearch.com/post/the-truth-about-tpl-horizon-and-the-asset-liability-mismatch" title="https://www.gothamcityresearch.com/post/the-truth-about-tpl-horizon-and-the-asset-liability-mismatch">https://www.gothamcityresearch.com/post/the-truth-about-tpl-horizon-and-the-asset-liability-mismatch</a>

News

Short Sellers

Trading Ideas

Watching Texas Pacific Land; Gotham City Research Issues Report On Co, Says "We believe shares will approach $361-$440 per share, implying  53%-61% downside vs current price."

GrafTech International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) is gearing up to announce its quarterly earnings on Friday, 2025-07-25. Here's a quick overview of what investors should know before the release.
Analysts are estimating that GrafTech International will report an earnings per share (EPS) of $-0.11.
Investors in GrafTech International are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company missed EPS by $0.00, leading to a 0.0% drop in the share price the following trading session.
Here's a look at GrafTech International's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.13</td>
<td>-0.13</td>
<td>-0.09</td>
<td>-0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.13</td>
<td>-0.13</td>
<td>-0.13</td>
<td>-0.05</td>
</tr>
<tr>
<td>Price Change %</td>
<td>8.0%</td>
<td>-9.0%</td>
<td>-1.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753369355_0.png" alt="eps graph" />
<h3>GrafTech International Share Price Analysis</h3>
Shares of GrafTech International were trading at $1.42 as of July 23. Over the last 52-week period, shares are up 86.13%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/EAF/earnings">To track all earnings releases for GrafTech International visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Earnings Preview: GrafTech International

WIIM

Community Health Systems shares are trading lower following Q2 reported financial results. Additionally, Jefferies downgraded the stock from Buy to Hold and cut its price target from $4.25 to $3 while Barclays cut its price target from $4 to $3.5.

Citigroup analyst Andrew Kaplowitz maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Neutral and raises the price target from $544 to $670.

Price Target

Analyst Ratings

Citigroup Maintains Neutral on GE Vernova, Raises Price Target to $670

Central Pacific Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPF#NYSE">CPF</a>) will release its quarterly earnings report on Friday, 2025-07-25. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Central Pacific Financial to report an earnings per share (EPS) of $0.70.
Central Pacific Financial bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.02, leading to a 2.27% drop in the share price on the subsequent day.
Here's a look at Central Pacific Financial's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.63</td>
<td>0.62</td>
<td>0.56</td>
<td>0.47</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.65</td>
<td>0.70</td>
<td>0.58</td>
<td>0.58</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>5.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753369345_0.png" alt="eps graph" />
<h3>Market Performance of Central Pacific Financial's Stock</h3>
Shares of Central Pacific Financial were trading at $28.45 as of July 23. Over the last 52-week period, shares are up 8.16%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CPF/earnings">To track all earnings releases for Central Pacific Financial visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Central Pacific Financial's Earnings Outlook

Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) on Thursday revealed preclinical data from the H5N1 avian pandemic <a target="_blank" href="https://www.benzinga.com/general/biotech" rel="noreferrer noopener">influenza vaccine candidate</a>.
Leveraging Novavax&#8217;s recombinant, protein-based nanoparticle technology and Matrix-M adjuvant, the vaccine candidate induced robust immune responses in nonhuman primates after either single—or two-dose intranasal (IN) or intramuscular (IM) administration.
Results showed that a single dose administered by either IN or IM routes induced neutralizing antibody responses (IN: 1:54; IM: 1:1,160), at or above the 1:40 titer generally considered a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46598480/novavaxs-h5n1-vaccine-candidate-demonstrates-immunogenicity-in-preclinical-study" rel="noreferrer noopener">protective antibody response</a>.
The data showed even higher levels of immunity after two doses.
These data suggest that even a single IN dose can provide protective immunity in individuals previously exposed to seasonal influenza by vaccination or infection.
Further, data showed Novavax&#8217;s H5N1 vaccine candidate elicited broad antibody responses, suggesting the potential to protect against forward-drift variants from currently circulating strains of the H5N1 virus.&nbsp;
Results were published in <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4474330-1&amp;h=3805448881&amp;u=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41467-025-61964-y&amp;a=Nature+Communications" target="_blank" rel="noreferrer noopener">Nature Communications</a>. 
H5N1 is a highly pathogenic and virulent avian pandemic influenza virus, commonly referred to as &#8220;bird flu.&#8221;
There have been 70 confirmed total reported human cases in the U.S., and one death associated with H5N1 avian pandemic influenza infection.
As of July 2025, no reported cases in the U.S. have been proven to result from human-to-human transmission.&nbsp;
Novavax intends to pursue funding, partnership, and licensing opportunities for its H5N1 vaccine candidate.&nbsp;
In June, Novavax announced results from the initial cohort of its COVID-19-Influenza Combination (CIC) and standalone&nbsp;trivalent hemagglutinin nanoparticle&nbsp;seasonal <a target="_blank" href="https://www.benzinga.com/news/health-care/25/06/45887132/novavaxs-experimental-covid-19-influenza-combo-shot-shows-immune-response-among-older-adults-in-phase-3-trial" rel="noreferrer noopener">influenza (tNIV) Phase 3 trial</a>.
The study showed that the CIC and flu vaccine candidates induced immune responses similar to those of licensed comparators Nuvaxovid&nbsp;and Sanofi SA's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/n45879363/novavaxs-covid-19-influenza-combination-and-stand-alone-influenza-vaccine-candidates-showed-robust" rel="noreferrer noopener">Fluzone HD, respectively</a>.
Both standalone flu and CIC vaccine candidates induced robust immune responses to the vaccine strains (2.4-5.7-fold over baseline).
In May, Novavax received limited approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Nuvaxovid, marking a regulatory milestone and unlocking a $175 million milestone <a target="_blank" href="https://www.benzinga.com/25/05/45496095/novavax-scores-key-fda-win-shares-jump-19-as-sanofi-milestone-unlock" rel="noreferrer noopener">payment from Sanofi</a>.
Price Action: NVAX stock is up 5.61% at $8.28 at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/m-a/25/07/46597484/botswana-seeks-diamond-dominance-eyes-majority-of-de-beers" target="_blank" rel="noreferrer noopener">Botswana Seeks Diamond Dominance, Eyes Majority Of De Beers</a></li>
</ul>
Image: Shutterstock

Biotech

Health Care

Movers

General

NVAX

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Southside Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBSI#NASDAQ">SBSI</a>) will release its quarterly earnings report on Friday, 2025-07-25. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Southside Bancshares to report an earnings per share (EPS) of $0.68.
Southside Bancshares bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company beat EPS by $0.03, leading to a 1.71% drop in the share price the following trading session.
Here's a look at Southside Bancshares's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.68</td>
<td>0.71</td>
<td>0.73</td>
<td>0.64</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.71</td>
<td>0.71</td>
<td>0.68</td>
<td>0.81</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-0.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753369333_0.png" alt="eps graph" />
<h3>Market Performance of Southside Bancshares's Stock</h3>
Shares of Southside Bancshares were trading at $30.97 as of July 23. Over the last 52-week period, shares are down 9.41%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/SBSI/earnings">To track all earnings releases for Southside Bancshares visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SBSI

Southside Bancshares's Earnings Outlook

Stellar Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEL#NYSE">STEL</a>) is set to give its latest quarterly earnings report on Friday, 2025-07-25. Here's what investors need to know before the announcement.
Analysts estimate that Stellar Bancorp will report an earnings per share (EPS) of $0.45. 
Anticipation surrounds Stellar Bancorp's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.02, leading to a 0.0% drop in the share price the following trading session.
Here's a look at Stellar Bancorp's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.44</td>
<td>0.49</td>
<td>0.48</td>
<td>0.48</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.46</td>
<td>0.52</td>
<td>0.63</td>
<td>0.56</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-1.0%</td>
<td>0.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753369319_0.png" alt="eps graph" />
<h3>Tracking Stellar Bancorp's Stock Performance</h3>
Shares of Stellar Bancorp were trading at $32.11 as of July 23. Over the last 52-week period, shares are up 14.32%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/STEL/earnings">To track all earnings releases for Stellar Bancorp visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

STEL

A Glimpse of Stellar Bancorp's Earnings Potential

Investors with a lot of money to spend have taken a bullish stance on Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ALAB, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Astera Labs.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 10%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $36,148, and 9, calls, for a total amount of $504,503.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $75.0 to $150.0 for Astera Labs during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Astera Labs's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Astera Labs's whale trades within a strike price range from $75.0 to $150.0 in the last 30 days. 
<h3>Astera Labs Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753369314_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$35.3</td>
<td>$35.3</td>
<td>$35.3</td>
<td>$90.00</td>
<td>$116.4K</td>
<td align="right">458</td>
<td align="right">33</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/08/25</td>
<td>$7.2</td>
<td>$6.1</td>
<td>$7.2</td>
<td>$130.00</td>
<td>$72.0K</td>
<td align="right">140</td>
<td align="right">0</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$22.5</td>
<td>$22.3</td>
<td>$22.5</td>
<td>$100.00</td>
<td>$67.5K</td>
<td align="right">852</td>
<td align="right">31</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$8.7</td>
<td>$8.5</td>
<td>$8.66</td>
<td>$125.00</td>
<td>$51.1K</td>
<td align="right">433</td>
<td align="right">61</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$16.0</td>
<td>$15.6</td>
<td>$15.8</td>
<td>$110.00</td>
<td>$47.4K</td>
<td align="right">731</td>
<td align="right">32</td>
</tr>
</tbody>
</table>

<h3>About Astera Labs</h3>
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.
In light of the recent options history for Astera Labs, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Astera Labs Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,043,205, with ALAB's price up by 1.41%, positioned at $121.17.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 12 days.</li>
</ul>
<h3>Professional Analyst Ratings for Astera Labs</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $120.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Astera Labs with a target price of $130. 
&#x2A; Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Astera Labs with a target price of $110. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Astera Labs, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

ALAB

Smart Money Is Betting Big In ALAB Options

Lakeland Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKFN#NASDAQ">LKFN</a>) is preparing to release its quarterly earnings on Friday, 2025-07-25. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Lakeland Financial to report an earnings per share (EPS) of $0.95.
Anticipation surrounds Lakeland Financial's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS missed by $0.11, leading to a 0.0% drop in the share price on the subsequent day.
Here's a look at Lakeland Financial's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.89</td>
<td>0.90</td>
<td>0.88</td>
<td>0.85</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.78</td>
<td>0.94</td>
<td>0.91</td>
<td>0.74</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>3.0%</td>
<td>-4.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753369310_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Lakeland Financial were trading at $64.92 as of July 23. Over the last 52-week period, shares are down 9.48%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/LKFN/earnings">To track all earnings releases for Lakeland Financial visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LKFN

Earnings Preview For Lakeland Financial

Deep-pocketed investors have adopted a bullish approach towards Shopify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NASDAQ">SHOP</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SHOP usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Shopify. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 76% leaning bullish and 23% bearish. Among these notable options, 8 are puts, totaling $1,259,112, and 5 are calls, amounting to $226,175.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $140.0 for Shopify, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Shopify's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Shopify's significant trades, within a strike price range of $100.0 to $140.0, over the past month.
<h3>Shopify Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753369309_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$10.15</td>
<td>$10.05</td>
<td>$10.05</td>
<td>$120.00</td>
<td>$723.6K</td>
<td>605</td>
<td align="right">728</td>
</tr>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$4.85</td>
<td>$4.75</td>
<td>$4.75</td>
<td>$110.00</td>
<td>$296.8K</td>
<td>2.1K</td>
<td align="right">655</td>
</tr>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$6.6</td>
<td>$6.45</td>
<td>$6.45</td>
<td>$100.00</td>
<td>$77.4K</td>
<td>2.4K</td>
<td align="right">195</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$24.5</td>
<td>$24.2</td>
<td>$24.25</td>
<td>$140.00</td>
<td>$58.2K</td>
<td>91</td>
<td align="right">24</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$18.85</td>
<td>$18.8</td>
<td>$18.8</td>
<td>$105.00</td>
<td>$56.4K</td>
<td>494</td>
<td align="right">33</td>
</tr>
</tbody>
</table>

<h3>About Shopify</h3>
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.
Following our analysis of the options activities associated with Shopify, we pivot to a closer look at the company's own performance.
<h3>Where Is Shopify Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,007,191, with SHOP's price up by 0.56%, positioned at $122.9.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 13 days.</li>
</ul>
<h3>What Analysts Are Saying About Shopify</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $126.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $135. 
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Shopify with a target price of $145. 
&#x2A; Maintaining their stance, an analyst from Baird continues to hold a Outperform rating for Shopify, targeting a price of $120. 
&#x2A; Reflecting concerns, an analyst from Loop Capital lowers its rating to Hold with a new price target of $120. 
&#x2A; Maintaining their stance, an analyst from Stifel continues to hold a Hold rating for Shopify, targeting a price of $110. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Shopify options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

SHOP

Unpacking the Latest Options Trading Trends in Shopify

High-rolling investors have positioned themselves bearish on CRISPR Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CRSP often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for CRISPR Therapeutics. This is not a typical pattern.
The sentiment among these major traders is split, with 25% bullish and 50% bearish. Among all the options we identified, there was one put, amounting to $111,000, and 7 calls, totaling $464,666.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $25.0 and $110.0 for CRISPR Therapeutics, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for CRISPR Therapeutics's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across CRISPR Therapeutics's significant trades, within a strike price range of $25.0 to $110.0, over the past month.
<h3>CRISPR Therapeutics Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753369304_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$9.6</td>
<td>$9.2</td>
<td>$9.27</td>
<td>$60.00</td>
<td>$222.8K</td>
<td>3.5K</td>
<td align="right">251</td>
</tr>
<tr>
<td>CRSP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$44.7</td>
<td>$44.2</td>
<td>$44.4</td>
<td>$110.00</td>
<td>$111.0K</td>
<td>505</td>
<td align="right">25</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$3.7</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$72.00</td>
<td>$56.7K</td>
<td>18</td>
<td align="right">18</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$44.9</td>
<td>$44.0</td>
<td>$44.0</td>
<td>$25.00</td>
<td>$44.0K</td>
<td>205</td>
<td align="right">10</td>
</tr>
<tr>
<td>CRSP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$70.00</td>
<td>$43.2K</td>
<td>2.2K</td>
<td align="right">159</td>
</tr>
</tbody>
</table>

<h3>About CRISPR Therapeutics</h3>
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.
Having examined the options trading patterns of CRISPR Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of CRISPR Therapeutics</h3>
<ul>
<li>Trading volume stands at 891,759, with CRSP's price up by 1.26%, positioned at $69.0.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 11 days.</li>
</ul>
<h3>Expert Opinions on CRISPR Therapeutics</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $75.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Chardan Capital continues to hold a Buy rating for CRISPR Therapeutics, targeting a price of $82. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $81. 
&#x2A; An analyst from Clear Street has revised its rating downward to Hold, adjusting the price target to $45. 
&#x2A; Reflecting concerns, an analyst from JMP Securities lowers its rating to Market Outperform with a new price target of $86. 
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $81. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CRISPR Therapeutics, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

CRSP

What the Options Market Tells Us About CRISPR Therapeutics

Gorman-Rupp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRC#NYSE">GRC</a>) is gearing up to announce its quarterly earnings on Friday, 2025-07-25. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Gorman-Rupp will report an earnings per share (EPS) of $0.56.
Anticipation surrounds Gorman-Rupp's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.02, leading to a 0.48% increase in the share price the following trading session.
Here's a look at Gorman-Rupp's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.44</td>
<td>0.45</td>
<td>0.55</td>
<td>0.33</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.46</td>
<td>0.42</td>
<td>0.49</td>
<td>0.54</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>-3.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753369299_0.png" alt="eps graph" />
<h3>Performance of Gorman-Rupp Shares</h3>
Shares of Gorman-Rupp were trading at $37.94 as of July 23. Over the last 52-week period, shares are down 8.17%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/GRC/earnings">To track all earnings releases for Gorman-Rupp visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Examining the Future: Gorman-Rupp's Earnings Outlook

It was revealed in a recent SEC filing that Brian Loftus, SVP at Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) made a noteworthy insider purchase on July 23,.
What Happened: Loftus demonstrated confidence in Sun Communities by purchasing 3,736 shares, as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000912593/000091259325000201//Archives/edgar/data/912593/000091259325000201/0000912593-25-000201-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday. The total value of the transaction is $467,224.
Monitoring the market, Sun Communities's shares down by 1.49% at $122.45 during Thursday's morning.
<h3>Discovering Sun Communities: A Closer Look</h3>
Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 502 properties, which includes 337 manufactured housing communities and 165 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.
<h3>Financial Insights: Sun Communities</h3>
Positive Revenue Trend: Examining Sun Communities's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.24% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Exploring Profitability:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 51.48%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Sun Communities's EPS reflects a decline, falling below the industry average with a current EPS of -0.34.
</li>
</ul>
Debt Management: Sun Communities's debt-to-equity ratio is below the industry average at 1.06, reflecting a lower dependency on debt financing and a more conservative financial approach.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: Sun Communities's current Price to Earnings (P/E) ratio of 149.7 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 4.97 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 20.79, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
</li>
</ul>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Transaction Codes Worth Your Attention</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000912593">Check Out The Full List Of Sun Communities's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Smart Money Move: Brian Loftus Grabs $467K Worth Of Sun Communities Stock

Portland Gen Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POR#NYSE">POR</a>) will release its quarterly earnings report on Friday, 2025-07-25. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Portland Gen Electric to report an earnings per share (EPS) of $0.64.
The market awaits Portland Gen Electric's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings History Snapshot</h3>
In the previous earnings release, the company missed EPS by $0.08, leading to a 0.0% drop in the share price the following trading session.
Here's a look at Portland Gen Electric's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.99</td>
<td>0.35</td>
<td>0.87</td>
<td>0.62</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.91</td>
<td>0.36</td>
<td>0.90</td>
<td>0.69</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753369289_0.png" alt="eps graph" />
<h3>Portland Gen Electric Share Price Analysis</h3>
Shares of Portland Gen Electric were trading at $40.09 as of July 23. Over the last 52-week period, shares are down 15.73%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/POR/earnings">To track all earnings releases for Portland Gen Electric visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For Portland Gen Electric

John B. McLaren, President at Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>), reported an insider buy on July 23, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000912593/000091259325000202//Archives/edgar/data/912593/000091259325000202/0000912593-25-000202-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that McLaren purchased 4,788 shares of Sun Communities. The total transaction amounted to $598,787. 
Sun Communities's shares are actively trading at $122.45, experiencing a down of 1.49% during Thursday's morning session.
<h3>Delving into Sun Communities's Background</h3>
Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 502 properties, which includes 337 manufactured housing communities and 165 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.
<h3>Sun Communities's Economic Impact: An Analysis</h3>
Revenue Growth: Sun Communities's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 0.24%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: With a low gross margin of 51.48%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Sun Communities's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of -0.34.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 1.06, Sun Communities adopts a prudent financial strategy, indicating a balanced approach to debt management.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 149.7 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 4.97 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an impressive EV/EBITDA ratio of 20.79, Sun Communities demonstrates exemplary market valuation, surpassing industry averages.
</li>
</ul>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Insider transactions contribute to decision-making but should be supplemented by a comprehensive investment analysis.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>Exploring Key Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000912593">Check Out The Full List Of Sun Communities's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Smart Money Move: John B. McLaren Grabs $598K Worth Of Sun Communities Stock

Disclosed in the latest SEC filing, a significant insider purchase on July 23, involves Bruce Thelen, EVP at Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>).
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000912593/000091259325000204//Archives/edgar/data/912593/000091259325000204/0000912593-25-000204-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday unveiled that Thelen made a notable purchase of 11,989 shares of Sun Communities, valuing at $1,499,344.
As of Thursday morning, Sun Communities shares are down by 1.49%, currently priced at $122.45.
<h3>Discovering Sun Communities: A Closer Look</h3>
Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 502 properties, which includes 337 manufactured housing communities and 165 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.
<h3>Financial Insights: Sun Communities</h3>
Revenue Growth: Over the 3 months period, Sun Communities showcased positive performance, achieving a revenue growth rate of 0.24% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Profitability Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 51.48%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, Sun Communities exhibits below-average bottom-line performance with a current EPS of -0.34.
</li>
</ul>
Debt Management: Sun Communities's debt-to-equity ratio is below the industry average. With a ratio of 1.06, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 149.7, Sun Communities's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 4.97, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 20.79 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Understanding Crucial Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000912593">Check Out The Full List Of Sun Communities's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sun Communities EVP Makes $1.50M Stock Purchase

Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) will release its quarterly earnings report on Friday, 2025-07-25. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Lear to report an earnings per share (EPS) of $3.27.
Lear bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings History Snapshot</h3>
The company's EPS beat by $0.42 in the last quarter, leading to a 0.46% drop in the share price on the following day.
Here's a look at Lear's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.70</td>
<td>2.58</td>
<td>2.63</td>
<td>3.4</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>3.12</td>
<td>2.94</td>
<td>2.89</td>
<td>3.6</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>2.0%</td>
<td>0.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753369278_0.png" alt="eps graph" />
<h3>Market Performance of Lear's Stock</h3>
Shares of Lear were trading at $108.79 as of July 23. Over the last 52-week period, shares are down 10.41%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Observations about Lear</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Lear.
Lear has received a total of 10 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $110.9, the consensus suggests a potential 1.94% upside.
<h3>Peer Ratings Comparison</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Gentex, Modine Manufacturing and BorgWarner, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Gentex, with an average 1-year price target of $24.5, suggesting a potential 77.48% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Modine Manufacturing, with an average 1-year price target of $122.67, suggesting a potential 12.76% upside.</li>
<li>Analysts currently favor an Neutral trajectory for BorgWarner, with an average 1-year price target of $39.56, suggesting a potential 63.64% downside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
The peer analysis summary offers a detailed examination of key metrics for Gentex, Modine Manufacturing and BorgWarner, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lear</td>
<td>Neutral</td>
<td>-7.24%</td>
<td>$359.20M</td>
<td>1.77%</td>
</tr>
<tr>
<td>Gentex</td>
<td>Neutral</td>
<td>-2.28%</td>
<td>$191.73M</td>
<td>3.78%</td>
</tr>
<tr>
<td>Modine Manufacturing</td>
<td>Outperform</td>
<td>7.24%</td>
<td>$166M</td>
<td>5.62%</td>
</tr>
<tr>
<td>BorgWarner</td>
<td>Neutral</td>
<td>-2.23%</td>
<td>$639M</td>
<td>2.79%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Lear is positioned in the middle among its peers for revenue growth, with one company outperforming and two underperforming. In terms of gross profit, Lear ranks at the top. For return on equity, Lear is in the middle compared to its peers.
<h3>About Lear</h3>
Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.
<h3>Lear's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Lear's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -7.24%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Lear's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.45% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Lear's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.77%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Lear's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.56% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Lear's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.59.
<a href="https://www.benzinga.com/quote/LEA/earnings">To track all earnings releases for Lear visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What's Next: Lear's Earnings Preview

A significant insider buy by Aaron Weiss, EVP at Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>), was executed on July 23, and reported in the recent SEC filing.
What Happened: In a recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000912593/000091259325000208//Archives/edgar/data/912593/000091259325000208/0000912593-25-000208-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, Weiss increased their investment in Sun Communities by purchasing 15,253 shares through open-market transactions, signaling confidence in the company's potential. The total transaction value is $1,907,540.
As of Thursday morning, Sun Communities shares are down by 1.49%, currently priced at $122.45.
<h3>About Sun Communities</h3>
Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 502 properties, which includes 337 manufactured housing communities and 165 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.
<h3>Breaking Down Sun Communities's Financial Performance</h3>
Revenue Growth: Sun Communities's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 0.24%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 51.48%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Sun Communities's EPS reflects a decline, falling below the industry average with a current EPS of -0.34.
</li>
</ul>
Debt Management: Sun Communities's debt-to-equity ratio is below the industry average at 1.06, reflecting a lower dependency on debt financing and a more conservative financial approach.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: A higher-than-average P/E ratio of 149.7 suggests caution, as the stock may be overvalued in the eyes of investors.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 4.97 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 20.79, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
</li>
</ul>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000912593">Check Out The Full List Of Sun Communities's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sun Communities EVP Trades $1.91M In Company Stock

Disclosed on July 23, Randall K Fields, Chief Executive Officer at ReposiTrak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRAK#NYSE">TRAK</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: Fields's recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000050471/000141588925020205//Archives/edgar/data/50471/000141588925020205/0001415889-25-020205-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday unveiled the sale of 7,500 shares of ReposiTrak. The total transaction value is $137,566.
At Thursday morning, ReposiTrak shares are down by 0.0%, trading at $18.41.
<h3>Unveiling the Story Behind ReposiTrak</h3>
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.
<h3>ReposiTrak: Financial Performance Dissected</h3>
Revenue Growth: Over the 3 months period, ReposiTrak showcased positive performance, achieving a revenue growth rate of 16.3% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Evaluating Earnings Performance:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 84.58%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): ReposiTrak's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.1.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.02.
Exploring Valuation Metrics Landscape:
<ul>
<li>
Price to Earnings (P/E) Ratio: ReposiTrak's current Price to Earnings (P/E) ratio of 54.15 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 15.98 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio of 35.85, the company's market valuation exceeds industry averages.
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000050471">Check Out The Full List Of ReposiTrak's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Franklin FTSE United Kingdom ETF

Vendite allo scoperto

Franklin FTSE United Kingdom ETF (ARCA:FLGB), Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO